| Name | Title | Contact Details |
|---|
INVENTIV COMMUNICATIONS is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Neurostream Technologies is a Saint-Augustin-De-Desmaures, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1988, Health Design Plus (HDP) initially a Care Management company, expanded its suite of services to include network development/management and claims administration. With over 25 years of continued success, Health Design Plus continues to offer new products, such as Good Health by Design®, a suite of Wellness programs including LifeStart®, a Maternity Management program, Wellness Counts®, a biometric screening and coaching program, Carewise®, a Care Management program, and Healthy Living™, a Disease Management program, designed to fit all wellness-readiness levels, promoting healthier lifestyle choices and behavior modification to reach personal goals. Health Design Plus helps clients fuel their fiscal health in the marketplace while improving the health of their employees and members. Recently, HDP has gained national recognition as the industry leader in Domestic Travel Surgery programs with the launch of CliniFIT™ Centers of Excellence. HDP`s CliniFIT™ Centers of Excellence programs offer employers unparalleled commitment to consistently deliver safe, effective, evidence-based care. Qualified employees have access to recognized leaders in specific fields of medicine, Cardiac, Spine and Joint Replacement.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
We aim to make personalized brain health a reality.For everyone. Linus Health integrates the latest in cutting-edge neuroscience and AI technology with everyday digital tools to give individuals and their care professionals up-to-the-minute brain healt...